Infectious complications related to intrathecal drug delivery system and spinal cord stimulator system implantations at a comprehensive cancer pain center

Pain Physician

Volumn 16, Issue 3, 2013, Pages 251-257

  Engle, Mitchell P ^a   Vinh, Baominh P ^a,b   Harun, Nusrat ^a   Koyyalagunta, Dhanalaksmi ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b NONE

Author keywords

Complications; Implantable pain therapies; Infection; Intrathecal drug delivery; Neuromodulation; Pain; Pain procedures; Spinal cord stimulation; Surgical site infection

Indexed keywords

ANTIBIOTIC AGENT; CEFAZOLIN;

ADULT; ANTIBIOTIC PROPHYLAXIS; CANCER CENTER; CANCER PAIN; CANCER PATIENT; CHRONIC PAIN; COMORBIDITY; CONTROLLED STUDY; DEVICE REMOVAL; DRUG DELIVERY DEVICE; FEMALE; FOLLOW UP; HIGH RISK POPULATION; HUMAN; IMPLANTABLE PULSE GENERATOR; IMPLANTED SPINAL CORD STIMULATOR; INFECTION RATE; INFECTION SENSITIVITY; INFECTIOUS COMPLICATION; INFUSION PUMP; INTRATHECAL DRUG DELIVERY SYSTEM; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MORTALITY; OPERATION DURATION; PAIN CLINIC; PERIOPERATIVE PERIOD; RETROSPECTIVE STUDY; REVIEW; RISK FACTOR; SURGICAL INFECTION;

CROSS INFECTION; DRUG DELIVERY SYSTEMS; FEMALE; HUMANS; INJECTIONS, SPINAL; MALE; MIDDLE AGED; NEOPLASMS; PAIN; PAIN CLINICS; PAIN MANAGEMENT; RETROSPECTIVE STUDIES; SPINAL CORD STIMULATION; TREATMENT OUTCOME;

EID: 84878224985     PISSN: 15333159     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (29)

1. Anonymous. Cancer Pain Relief. 2nd edition. World Health Organization, Geneva, 1996.
2. Meuser T, Pietruck C, Radbruch L, Stute P, Lehmann KA, Grond S. Symptoms during cancer pain treatment following WHO-guidelines: A longitudinal followup study of symptom prevalence, severity and etiology. Pain 2001; 93:247-257.
3. Christo PJ, Mazloomdoost D. Cancer pain and analgesia. Annals of the New York Academy of Sciences 2008; 1138:278-298.
4. Smith TJ, Staats PS, Deer T, Stearns LJ, Rauck RL, Boortz-Marx RL, Buchser E, Catala E, Bryce DA, Coyne PJ, Pool GE, Implantable Drug Delivery Systems Study Group{?}. Randomized clinical trial of an implantable drug delivery system compared with comprehensive medical management for refractory cancer pain: Impact on pain, drug-related toxicity, and survival. J Clin Oncol 2002; 20:4040-4049.
5. Burton AW, Rajagopal A, Shah HN, Mendoza T, Cleeland C, Hassenbusch SJ, 3rd, Arens JF. Epidural and intrathecal analgesia is effective in treating refractory cancer pain. Pain Med 2004:5: 239-247.
6. Stearns L, Boortz-Marx R, Du Pen S, Friehs G, Gordon M, Halyard M, Herbst L, Kiser J. Intrathecal drug delivery for the management of cancer pain: A multidisciplinary consensus of best clinical practices. J Support Oncol 2005; 3:399-408.
7. Deer TR, Smith HS, Burton AW, Pope JE, Doleys DM, Levy RM, Staats PS, Wallace MS, Webster LR, Rauck RL, Cousins M, Center For Pain Relief I{?}. Comprehensive consensus based guidelines on intrathecal drug delivery systems in the treatment of pain caused by cancer pain. Pain Physician 2011; 14:E283-312.
8. Viswanathan A, Phan PC, Burton AW. Use of spinal cord stimulation in the treatment of phantom limb pain: Case series and review of the literature. Pain Pract 2010; 10:479-484.
9. Cata JP, Cordella JV, Burton AW, Hassenbusch SJ, Weng HR, Dougherty PM. Spinal cord stimulation relieves chemotherapy-induced pain: A clinical case report. Journal of pain and symptom management 2004; 27:72-78.
10. Smith TJ, Coyne PJ, Staats PS, Deer T, Stearns LJ, Rauck RL, Boortz-Marx RL, Buchser E, Catala E, Bryce DA, Cousins M, Pool GE. An implantable drug delivery system (IDDS) for refractory cancer pain provides sustained pain control, less drug-related toxicity, and possibly better survival compared with comprehensive medical management (CMM). Annals of oncology: Official journal of the European Society for Medical Oncology / ESMO 2005; 16:825-833.
11. Mangram AJ, Horan TC, Pearson ML, Silver LC, Jarvis WR. Guideline for prevention of surgical site infection, 1999. Centers for Disease Control and Prevention (CDC) Hospital Infection Control Practices Advisory Committee. Am J Infect Control 1999; 27:97-132; quiz 133-134; discussion 196.
12. Follett KA, Boortz-Marx RL, Drake JM, DuPen S, Schneider SJ, Turner MS, Coffey RJ. Prevention and management of intrathecal drug delivery and spinal cord stimulation system infections. Anesthesiology 2004; 100:1582-1594.
13. Neumayer L, Hosokawa P, Itani K, El-Tamer M, Henderson WG, Khuri SF. Multivariable predictors of postoperative surgical site infection after general and vascular surgery: Results from the patient safety in surgery study. Journal of the American College of Surgeons 2007; 204:1178-1187.
14. Sorensen LT. Wound healing and infection in surgery. The clinical impact of smoking and smoking cessation: A systematic review and meta-analysis. Arch Surg 2012; 147:373-383.
15. de Courcy JG. Interventional techniques for cancer pain management. Clin Oncol (R Coll Radiol) 2011; 23:407-417.
16. Kumar K, Taylor RS, Jacques L, Eldabe S, Meglio M, Molet J, Thomson S, O'Callaghan J, Eisenberg E, Milbouw G, Buchser E, Fortini G, Richardson J, North RB. Spinal cord stimulation versus conventional medical management for neuropathic pain: A multicentre randomised controlled trial in patients with failed back surgery syndrome. Pain 2007; 132:179-188.
17. Burgher AH, Barnett CF, Obray JB, Mauck WD. Introduction of infection control measures to reduce infection associated with implantable pain therapy devices. Pain Pract 2007; 7:279-284.
18. Ubbink DT, Vermeulen H, Spincemaille GH, Gersbach PA, Berg P, Amann W. Systematic review and meta-analysis of controlled trials assessing spinal cord stimulation for inoperable critical leg ischaemia. Br J Surg 2004; 91:948-955.
19. Mekhail NA, Mathews M, Nageeb F, Guirguis M, Mekhail MN, Cheng J. Retrospective review of 707 cases of spinal cord stimulation: indications and complications. Pain Pract 2011; 11:148-153.
20. Turner JA, Sears JM, Loeser JD. Programmable intrathecal opioid delivery systems for chronic noncancer pain: A systematic review of effectiveness and complications. Clin J Pain 2007; 23:180-195.
21. Turner JA, Loeser JD, Deyo RA, Sanders SB. Spinal cord stimulation for patients with failed back surgery syndrome or complex regional pain syndrome: A systematic review of effectiveness and complications. Pain 2004; 108:137-147.
22. Kumar K, Nath R, Wyant GM. Treatment of chronic pain by epidural spinal cord stimulation: A 10-year experience. J Neurosurg 1991; 75:402-407.
23. North RB, Kidd DH, Farrokhi F, Piantadosi SA. Spinal cord stimulation versus repeated lumbosacral spine surgery for chronic pain: A randomized, controlled trial. Neurosurgery 2005; 56:98-106; discussion 106-107.
24. Ventafridda V, Tamburini M, Caraceni A, De Conno F, Naldi F. A validation study of the WHO method for cancer pain relief. Cancer 1987; 59:850-856.
25. Miguel R. Interventional treatment of cancer pain: The fourth step in the World Health Organization analgesic ladder? Cancer Control 2000; 7:149-156.
26. Burton AW, Hamid B. Current challenges in cancer pain management: Does the WHO ladder approach still have relevance? Expert Rev Anticancer Ther 2007; 7:1501-1502.
27. Bunn F, Jones DJ, Bell-Syer S. Prophylactic antibiotics to prevent surgical site infection after breast cancer surgery. Cochrane Database Syst Rev 2012; 1:CD005360.
28. Pull ter Gunne AF, Cohen DB. Incidence, prevalence, and analysis of risk factors for surgical site infection following adult spinal surgery. Spine (Phila Pa 1976) 2009; 34:1422-1428.
29. Schimmel JJ, Horsting PP, de Kleuver M, Wonders G, van Limbeek J. Risk factors for deep surgical site infections after spinal fusion. European spine journal: Official publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society 2010; 19:1711-1719.